Search results
Biotech Stock Roundup: ITCI Up on Study Data, ZNTL, OVID Down on Updates & More News
Zacks via Yahoo News· 2 weeks agoIntra-Cellular Therapies (ITCI) and Zentalis Pharmaceuticals, Inc. (ZNTL) are in the spotlight...
Zentalis (ZNTL) Tanks After FDA Puts 3 Cancer Studies on Hold
Zacks via Yahoo News· 2 weeks agoZentalis' (ZNTL) three studies evaluating azenosertib for three different cancer indications face...
Viridian (VRDN) Up 10% on Clinical Updates for Eye Disease Drug
Zacks via Yahoo News· 3 weeks agoViridian (VRDN) intends to initiate two late-stage studies on its experimental thyroid eye disease...
Bristol Myers (BMY) Reports Positive Data on Breyanzi, Opdivo (Revised)
Zacks via Yahoo News· 1 month agoBristol Myers (BMY) announces positive data from three studies evaluating CAR T cell therapy...
Andrew Scott’s ‘Ripley’ Will Make Everyone Hot-For-Murderer
The Daily Beast via Yahoo News· 3 months agoPhoto Illustration by Luis G. Rendon/The Daily Beast/NetflixThere are roughly 47,000—oh, wait, a new...
Stoke Therapeutics (STOK) Up on Upbeat Dravet Syndrome Study Data
Zacks via Yahoo News· 3 months agoStoke Therapeutics, Inc. STOK reported encouraging new data from two phase I/IIa studies and two...
Cardiff (CRDF) Stock Rallies 194% in a Month: Here's Why
Zacks via Yahoo News· 3 months agoCardiff (CRDF) surges 194% in the past month, driven by investors' optimism regarding the potential...
Matt’s Inside Line: Scoop on NCIS, Ghosts, FBI: Most Wanted, Grey’s, TWD, Chicago P.D., Station 19...
TVLine.com via Yahoo News· 4 months agoWho has been (re)cast for a very special NCIS? What’s the prognosis for Grey’s Anatomy‘s new...
Applied Therapeutics (APLT) Surges 124% in a Month: Here's Why
Zacks via Yahoo News· 4 months agoApplied Therapeutics (APLT) surges 124% in a month due to encouraging updates from two separate...
Moderna (MRNA) Gears Up for Q4 Earnings: Will It Top Estimates?
Zacks via Yahoo News· 4 months agoInvestors' focus will likely be on updates on Moderna's (MRNA) pipeline, especially its late-stage...